The Medicines and Healthcare products Regulatory Agency (MHRA) consultation on the role and shape of the UK’s post-Brexit medical devices regulatory landscape is exactly halfway through the 10 weeks given. In a perfect world, the responses would be graded, analyzed and factored into legislation that is scheduled for release as a draft instrument in April 2022.
That would give 15 months for the legislation to get through parliament, be put in place and working at full...